CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print May 27, 2009
CA Cancer J Clin 2009; 59:225-249
doi: 10.3322/caac.20006
© 2009 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow All Versions of this Article:
caac.20006v1
caac.20006v2
caac.20006v3
59/4/225    most recent
Right arrow Submit a Comment to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when Comments are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jemal, A.
Right arrow Articles by Thun, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jemal, A.
Right arrow Articles by Thun, M. J.

Cancer Statistics, 2009

Ahmedin Jemal, DVM, PhD1, Rebecca Siegel, MPH2, Elizabeth Ward, PhD3, Yongping Hao, PhD4, Jiaquan Xu, MD5 and Michael J. Thun, MD, MS6

1Strategic Director, Cancer Surveillance, Surveillance and Health Policy Research, American Cancer Society, Atlanta, Georgia
2Manager, Surveillance Information Services, Surveillance and Health Policy Research, American Cancer Society, Atlanta, Georgia
3Vice President, Surveillance and Health Policy Research, American Cancer Society, Atlanta, Georgia
4Senior Epidemiologist, Surveillance and Health Policy Research, American Cancer Society, Atlanta, Georgia
5Epidemiologist, Mortality Statistics Branch, Division of Vital Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland
6Vice President Emeritus, Epidemiology and Surveillance Research, American Cancer Society, Atlanta, Georgia

Corresponding author: Ahmedin Jemal, DVM, PhD, Surveillance and Health Policy Research, American Cancer Society, 250 Williams Street, NW, Atlanta, GA 30303-1002; ahmedin.jemal{at}cancer.org

DISCLOSURES: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. The authors report no conflicts of interest.

Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Incidence and death rates are standardized by age to the 2000 United States standard million population. A total of 1,479,350 new cancer cases and 562,340 deaths from cancer are projected to occur in the United States in 2009. Overall cancer incidence rates decreased in the most recent time period in both men (1.8% per year from 2001 to 2005) and women (0.6% per year from 1998 to 2005), largely because of decreases in the three major cancer sites in men (lung, prostate, and colon and rectum [colorectum]) and in two major cancer sites in women (breast and colorectum). Overall cancer death rates decreased in men by 19.2% between 1990 and 2005, with decreases in lung (37%), prostate (24%), and colorectal (17%) cancer rates accounting for nearly 80% of the total decrease. Among women, overall cancer death rates between 1991 and 2005 decreased by 11.4%, with decreases in breast (37%) and colorectal (24%) cancer rates accounting for 60% of the total decrease. The reduction in the overall cancer death rates has resulted in the avoidance of about 650,000 deaths from cancer over the 15-year period. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, education, geographic area, and calendar year. Although progress has been made in reducing incidence and mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons younger than 85 years of age. Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population and by supporting new discoveries in cancer prevention, early detection, and treatment. CA Cancer J Clin 2009;59:225-249. © 2009 American Cancer Society, Inc.




This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
Y. Wang, T. Romigh, X. He, M. S. Orloff, R. H. Silverman, W. D. Heston, and C. Eng
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines
Hum. Mol. Genet., September 2, 2010; (2010) ddq354v2.
[Abstract] [Full Text] [PDF]

Home page
 Am J Clin PatholHome page
S. N. Konoplev, H. A. Fritsche, S. O'Brien, W. G. Wierda, M. J. Keating, T. G. Gornet, S. St Romain, X. Wang, K. Inamdar, M. R. Johnson, et al.
High Serum Thymidine Kinase 1 Level Predicts Poorer Survival in Patients With Chronic Lymphocytic Leukemia
Am J Clin Pathol, September 1, 2010; 134(3): 472 - 477.
[Abstract] [Full Text] [PDF]

Home page
 Am J Clin PatholHome page
J. S. Ross, J. Torres-Mora, N. Wagle, T. A. Jennings, and D. M. Jones
Biomarker-Based Prediction of Response to Therapy for Colorectal Cancer: Current Perspective
Am J Clin Pathol, September 1, 2010; 134(3): 478 - 490.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
L. M. S. Seeber, R. P. Zweemer, L. Marchionni, L. F. A. G. Massuger, V. T. H. B. M. Smit, W. M. van Baal, R. H. M. Verheijen, and P. J. van Diest
Methylation profiles of endometrioid and serous endometrial cancers
Endocr. Relat. Cancer, September 1, 2010; 17(3): 663 - 673.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
Y.-K. Leung, H.-M. Lam, S. Wu, D. Song, L. Levin, L. Cheng, C.-L. Wu, and S.-M. Ho
Estrogen receptor {beta}2 and {beta}5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion
Endocr. Relat. Cancer, September 1, 2010; 17(3): 675 - 689.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
G. Zalcman, E. Bergot, and E. Lechapt
Update on nonsmall cell lung cancer
Eur. Respir. Rev., September 1, 2010; 19(117): 173 - 185.
[Full Text] [PDF]

Home page
 ERRHome page
A. A. Armour and C. L. Watkins
The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer
Eur. Respir. Rev., September 1, 2010; 19(117): 186 - 196.
[Abstract] [Full Text] [PDF]

Home page
 Therapeutic Advances in Medical OncologyHome page
I. Okamoto, T. Mitsudomi, K. Nakagawa, and M. Fukuoka
The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutations
Therapeutic Advances in Medical Oncology, September 1, 2010; 2(5): 301 - 307.
[Abstract] [PDF]

Home page
 Therapeutic Advances in GastroenterologyHome page
I. Aroch, S. Kraus, I. Naumov, E. Ron, S. Shapira, D. Kazanov, N. Giladi, A. Litvak, S. Lev-Ari, A. Hallak, et al.
Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats
Therapeutic Advances in Gastroenterology, September 1, 2010; 3(5): 281 - 289.
[Abstract] [PDF]

Home page
 JCOHome page
E. Bruera and D. Hui
Integrating Supportive and Palliative Care in the Trajectory of Cancer: Establishing Goals and Models of Care
J. Clin. Oncol., September 1, 2010; 28(25): 4013 - 4017.
[Full Text] [PDF]

Home page
 JCOHome page
J. Tabernero and J. Baselga
Multigene Assays to Improve Assessment of Recurrence Risk and Benefit From Chemotherapy in Early-Stage Colon Cancer: Has the Time Finally Arrived, or Are We Still Stage Locked?
J. Clin. Oncol., September 1, 2010; 28(25): 3904 - 3907.
[Full Text] [PDF]

Home page
 Ann OncolHome page
S. Rajpar, C. Massard, A. Laplanche, E. Tournay, M. Gross-Goupil, Y. Loriot, M. Di Palma, A. Bossi, B. Escudier, A. Chauchereau, et al.
Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancer
Ann. Onc., September 1, 2010; 21(9): 1864 - 1869.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
F. Kassie, T. Melkamu, A. Endalew, P. Upadhyaya, X. Luo, and S. S. Hecht
Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination
Carcinogenesis, September 1, 2010; 31(9): 1634 - 1641.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
N. F. Wasserman, I. Aneas, and M. A. Nobrega
An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer
Genome Res., September 1, 2010; 20(9): 1191 - 1197.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
M. D. Bacolod and F. Barany
Gene Dysregulations Driven by Somatic Copy Number Aberrations-Biological and Clinical Implications in Colon Tumors: A Paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology
J. Mol. Diagn., September 1, 2010; 12(5): 552 - 561.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
V. Karoor, M. Le, D. Merrick, E. C. Dempsey, and Y. E. Miller
Vascular Endothelial Growth Factor Receptor 2-Targeted Chemoprevention of Murine Lung Tumors
Cancer Prevention Research, September 1, 2010; 3(9): 1141 - 1147.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
J. Gu, J. A. Ajani, E. T. Hawk, Y. Ye, J. H. Lee, M. S. Bhutani, W. L. Hofstetter, S. G. Swisher, K. K. Wang, and X. Wu
Genome-Wide Catalogue of Chromosomal Aberrations in Barrett's Esophagus and Esophageal Adenocarcinoma: A High-Density Single Nucleotide Polymorphism Array Analysis
Cancer Prevention Research, September 1, 2010; 3(9): 1176 - 1186.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
C. Jeronimo and M. Esteller
DNA Methylation Markers for Prostate Cancer with a Stem Cell Twist
Cancer Prevention Research, September 1, 2010; 3(9): 1053 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
I. Benakanakere, C. Besch-Williford, C. E. Carroll, and S. M. Hyder
Synthetic Progestins Differentially Promote or Prevent 7,12-Dimethylbenz(a)anthracene-Induced Mammary Tumors in Sprague-Dawley Rats
Cancer Prevention Research, September 1, 2010; 3(9): 1157 - 1167.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
D. Saleiro, G. Murillo, D. B. Lubahn, L. Kopelovich, K. S. Korach, and R. G. Mehta
Enhanced Induction of Mucin-Depleted Foci in Estrogen Receptor {beta} Knockout Mice
Cancer Prevention Research, September 1, 2010; 3(9): 1198 - 1204.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
M. W. Lingen
Screening for Oral Premalignancy and Cancer: What Platform and Which Biomarkers?
Cancer Prevention Research, September 1, 2010; 3(9): 1056 - 1059.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. Lengyel
Ovarian Cancer Development and Metastasis
Am. J. Pathol., September 1, 2010; 177(3): 1053 - 1064.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. T. Park, X. Chen, C. G. Trope, B. Davidson, I.-M. Shih, and T.-L. Wang
Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin
Am. J. Pathol., September 1, 2010; 177(3): 1087 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Yamaoka, T. Hara, and M. Kusaka
Overcoming Persistent Dependency on Androgen Signaling after Progression to Castration-Resistant Prostate Cancer
Clin. Cancer Res., September 1, 2010; 16(17): 4319 - 4324.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Li and J. L. Abbruzzese
New Strategies in Pancreatic Cancer: Emerging Epidemiologic and Therapeutic Concepts
Clin. Cancer Res., September 1, 2010; 16(17): 4313 - 4318.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Lauss, M. Ringner, and M. Hoglund
Prediction of Stage, Grade, and Survival in Bladder Cancer Using Genome-wide Expression Data: A Validation Study
Clin. Cancer Res., September 1, 2010; 16(17): 4421 - 4433.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. C. Pagliaro, D. L. Williams, D. Daliani, M. B. Williams, W. Osai, M. Kincaid, S. Wen, P. F. Thall, and C. A. Pettaway
Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study
J. Clin. Oncol., August 20, 2010; 28(24): 3851 - 3857.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
I. M. Thompson, D. P. Ankerst, and C. M. Tangen
Prostate-Specific Antigen, Risk Factors, and Prostate Cancer: Confounders Nestled in an Enigma
J Natl Cancer Inst, August 19, 2010; (2010) djq313v1.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
O. Bratt, H. Garmo, J. Adolfsson, A. Bill-Axelson, L. Holmberg, M. Lambe, and P. Stattin
Effects of Prostate-Specific Antigen Testing on Familial Prostate Cancer Risk Estimates
J Natl Cancer Inst, August 19, 2010; (2010) djq265v1.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
R. B. Riggins, M. M. Mazzotta, O. Z. Maniya, and R. Clarke
Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response
Endocr. Relat. Cancer, August 16, 2010; 17(3): R213 - R231.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
F. H. Sarkar, Y. Li, Z. Wang, and D. Kong
Novel targets for prostate cancer chemoprevention
Endocr. Relat. Cancer, August 16, 2010; 17(3): R195 - R212.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. J. Arcaroli, B. M. Touban, A. C. Tan, M. Varella-Garcia, R. W. Powell, S. G. Eckhardt, P. Elvin, D. Gao, and W. A. Messersmith
Gene Array and Fluorescence In situ Hybridization Biomarkers of Activity of Saracatinib (AZD0530), a Src Inhibitor, in a Preclinical Model of Colorectal Cancer
Clin. Cancer Res., August 15, 2010; 16(16): 4165 - 4177.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
U. Rudloff, L. M. Jacks, J. I. Goldberg, C. A. Wynveen, E. Brogi, S. Patil, and K. J. Van Zee
Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ
J. Clin. Oncol., August 10, 2010; 28(23): 3762 - 3769.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. Sala, M. Kataoka, N. Pandit-Taskar, N. Ishill, S. Mironov, C. S. Moskowitz, O. Mironov, M. A. Collins, D. S. Chi, S. Larson, et al.
Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients' Survival
Radiology, August 9, 2010; (2010) radiol.10092279v1.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
S. S. Groth, N. M. Rueth, J. S. Hodges, E. B. Habermann, R. S. Andrade, J. D'Cunha, and M. A. Maddaus
Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer.
Ann. Thorac. Surg., August 1, 2010; 90(2): 375 - 382.
[Abstract] [Full Text] [PDF]

Home page
 J Ultrasound MedHome page
J. K. Dave, F. Forsberg, S. Fernandes, C. W. Piccoli, T. B. Fox, D. A. Merton, L. M. Leodore, and A. L. Hall
Static and Dynamic Cumulative Maximum Intensity Display Mode for Subharmonic Breast Imaging: A Comparative Study With Mammographic and Conventional Ultrasound Techniques
J. Ultrasound Med., August 1, 2010; 29(8): 1177 - 1185.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Med.Home page
A. Vickers
Dutasteride reduces incident prostate cancer in men after negative prostate biopsy
Evid. Based Med., August 1, 2010; 15(4): 119 - 120.
[Full Text] [PDF]

Home page
 JCOHome page
H. L. Kindler, D. Niedzwiecki, D. Hollis, S. Sutherland, D. Schrag, H. Hurwitz, F. Innocenti, M. F. Mulcahy, E. O'Reilly, T. F. Wozniak, et al.
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
J. Clin. Oncol., August 1, 2010; 28(22): 3617 - 3622.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. Gordian, K. Ramachandran, I. M. Reis, M. Manoharan, M. S. Soloway, and R. Singal
Serum Free Circulating DNA Is a Useful Biomarker to Distinguish Benign versus Malignant Prostate Disease
Cancer Epidemiol. Biomarkers Prev., August 1, 2010; 19(8): 1984 - 1991.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Jemal, M. M. Center, C. DeSantis, and E. M. Ward
Global Patterns of Cancer Incidence and Mortality Rates and Trends
Cancer Epidemiol. Biomarkers Prev., August 1, 2010; 19(8): 1893 - 1907.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
M. Fassan, M. Pizzi, G. Battaglia, L. Giacomelli, P. Parente, P. Bocus, E. Ancona, and M. Rugge
Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis
J. Clin. Pathol., August 1, 2010; 63(8): 692 - 696.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
Y. Kawai, S. Sakano, Y. Suehiro, T. Okada, Y. Korenaga, T. Hara, K. Naito, H. Matsuyama, and Y. Hinoda
Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma
Ann. Onc., August 1, 2010; 21(8): 1612 - 1617.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
W. Chen, M. Chen, and L. S. Barak
Development of small molecules targeting the Wnt pathway for the treatment of colon cancer: a high-throughput screening approach
Am J Physiol Gastrointest Liver Physiol, August 1, 2010; 299(2): G293 - G300.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Chen, J. Gu, G. L. Delclos, A. M. Killary, Z. Fan, M. A. T. Hildebrandt, R. M. Chamberlain, H. B. Grossman, C. P. Dinney, and X. Wu
Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients
Carcinogenesis, August 1, 2010; 31(8): 1387 - 1391.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y. Suh, F. Afaq, N. Khan, J. J. Johnson, F. H. Khusro, and H. Mukhtar
Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells
Carcinogenesis, August 1, 2010; 31(8): 1424 - 1433.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
B. Liu, D. Chen, L. Yang, Y. Li, X. Ling, L. Liu, W. Ji, Y. Wei, J. Wang, Q. Wei, et al.
A functional variant (-1304T>G) in the MKK4 promoter contributes to a decreased risk of lung cancer by increasing the promoter activity
Carcinogenesis, August 1, 2010; 31(8): 1405 - 1411.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
G. L. Snyder and S. Greenberg
Effect of anaesthetic technique and other perioperative factors on cancer recurrence
Br. J. Anaesth., August 1, 2010; 105(2): 106 - 115.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
C. Eveno, J. Nemeth, H. Soliman, F. Praz, H. de The, P. Valleur, I. C. Talbot, and M. Pocard
Association With a High Number of Lymph Nodes and Microsatellite Instability in Colorectal Cancer--Reply
Arch Surg, August 1, 2010; 145(8): 799 - 800.
[Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
N. D. Facompre, K. El-Bayoumy, Y.-W. Sun, J. T. Pinto, and R. Sinha
1,4-Phenylenebis(Methylene)Selenocyanate, but Not Selenomethionine, Inhibits Androgen Receptor and Akt Signaling in Human Prostate Cancer Cells
Cancer Prevention Research, August 1, 2010; 3(8): 975 - 984.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
J. W. Kim, A. R. M. R. Amin, and D. M. Shin
Chemoprevention of Head and Neck Cancer with Green Tea Polyphenols
Cancer Prevention Research, August 1, 2010; 3(8): 900 - 909.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
Y. Xue, R. Johnson, M. DeSmet, P. W. Snyder, and J. C. Fleet
Generation of a Transgenic Mouse for Colorectal Cancer Research with Intestinal Cre Expression Limited to the Large Intestine
Mol. Cancer Res., August 1, 2010; 8(8): 1095 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. F. Akisik, K. Sandrasegaran, G. Bu, C. Lin, G. D. Hutchins, and E. G. Chiorean
Pancreatic Cancer: Utility of Dynamic Contrast-enhanced MR Imaging in Assessment of Antiangiogenic Therapy
Radiology, August 1, 2010; 256(2): 441 - 449.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
H. Yamaguchi, T. Kojima, T. Ito, Y. Kimura, M. Imamura, S. Son, J.-i. Koizumi, M. Murata, M. Nagayama, T. Nobuoka, et al.
Transcriptional Control of Tight Junction Proteins via a Protein Kinase C Signal Pathway in Human Telomerase Reverse Transcriptase-Transfected Human Pancreatic Duct Epithelial Cells
Am. J. Pathol., August 1, 2010; 177(2): 698 - 712.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. M. Merrill and B. D. Hunter
Conditional Survival Among Cancer Patients in the United States
Oncologist, August 1, 2010; 15(8): 873 - 882.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. Sangha, J. Price, and C. A. Butts
Adjuvant Therapy in Non-Small Cell Lung Cancer: Current and Future Directions
Oncologist, August 1, 2010; 15(8): 862 - 872.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. J. Hassett
The Full Burden of Cancer
Oncologist, August 1, 2010; 15(8): 793 - 795.
[Full Text] [PDF]

Home page
 The OncologistHome page
S. K. Taylor, S. Chia, S. Dent, M. Clemons, M. Agulnik, P. Grenci, L. Wang, A. M. Oza, P. Ivy, K. I. Pritchard, et al.
A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium
Oncologist, August 1, 2010; 15(8): 810 - 818.
[Abstract] [Full Text] [PDF]

Home page
 DatabaseHome page
T. Triplet, M. D. Shortridge, M. A. Griep, J. L. Stark, R. Powers, and P. Revesz
PROFESS: a PROtein Function, Evolution, Structure and Sequence database
Database, July 30, 2010; 2010(0): baq011 - baq011.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
P. J. Pickhardt and M. E. Hanson
Incidental Adnexal Masses Detected at Low-Dose Unenhanced CT in Asymptomatic Women Age 50 and Older: Implications for Clinical Management and Ovarian Cancer Screening
Radiology, July 27, 2010; (2010) radiol.10100511v1.
[Abstract] [Full Text]

Home page
 GutHome page
M. Bardou, A. Barkun, and M. Martel
Effect of statin therapy on colorectal cancer
Gut, July 26, 2010; (2010) gut.2009.190900v1.
[Abstract] [Full Text]

Home page
 Hum Mol GenetHome page
B. Johanneson, S. K. McDonnell, D. M. Karyadi, P. Quignon, L. McIntosh, S. M. Riska, L. M. FitzGerald, G. Johnson, K. Deutsch, G. Williams, et al.
Family-based association analysis of 42 hereditary prostate cancer families identifies the Apolipoprotein L3 region on chromosome 22q12 as a risk locus
Hum. Mol. Genet., July 22, 2010; (2010) ddq283v2.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. J. Lubner, M. R. Mahoney, J. L. Kolesar, N. K. LoConte, G. P. Kim, H. C. Pitot, P. A. Philip, J. Picus, W.-P. Yong, L. Horvath, et al.
Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study
J. Clin. Oncol., July 20, 2010; 28(21): 3491 - 3497.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
O. Arrieta, C. H. Gonzalez-De la Rosa, E. Arechaga-Ocampo, G. Villanueva-Rodriguez, T. L. Ceron-Lizarraga, L. Martinez-Barrera, M. E. Vazquez-Manriquez, M. A. Rios-Trejo, M. A. Alvarez-Avitia, N. Hernandez-Pedro, et al.
Randomized Phase II Trial of All-Trans-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non-Small-Cell Lung Cancer
J. Clin. Oncol., July 20, 2010; 28(21): 3463 - 3471.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
Z. Y. Wang, Y. X. Li, H. Wang, W. H. Wang, J. Jin, Y. P. Liu, Y. W. Song, S. L. Wang, X. F. Liu, and Z. H. Yu
Unfavorable prognosis of elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma
Ann. Onc., July 19, 2010; (2010) mdq347v2.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Wang, L.-E. Wang, L. Mao, M. R. Spitz, and Q. Wei
A Functional Variant of Tandem Repeats in Human Telomerase Gene Was Associated with Survival of Patients with Early Stages of Non-Small Cell Lung Cancer
Clin. Cancer Res., July 15, 2010; 16(14): 3779 - 3785.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Wu, W. Chang, J. Zhao, Y. Yu, X. Tan, T. Su, L. Zhao, S. Huang, S. Liu, and G. Cao
Development of Autoantibody Signatures as Novel Diagnostic Biomarkers of Non-Small Cell Lung Cancer
Clin. Cancer Res., July 15, 2010; 16(14): 3760 - 3768.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. M. Bennani-Baiti, A. Cooper, E. R. Lawlor, M. Kauer, J. Ban, D. N. T. Aryee, and H. Kovar
Intercohort Gene Expression Co-Analysis Reveals Chemokine Receptors as Prognostic Indicators in Ewing's Sarcoma
Clin. Cancer Res., July 15, 2010; 16(14): 3769 - 3778.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. Ng and D. Schrag
Microsatellite Instability and Adjuvant Fluorouracil Chemotherapy: A Mismatch?
J. Clin. Oncol., July 10, 2010; 28(20): 3207 - 3210.
[Full Text] [PDF]

Home page
 JCOHome page
T. D. Gilligan, J. Seidenfeld, E. M. Basch, L. H. Einhorn, T. Fancher, D. C. Smith, A. J. Stephenson, D. J. Vaughn, R. Cosby, and D. F. Hayes
American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors
J. Clin. Oncol., July 10, 2010; 28(20): 3388 - 3404.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
W. Zhang, T. Winder, Y. Ning, A. Pohl, D. Yang, M. Kahn, G. Lurje, M. J. LaBonte, P. M. Wilson, M. A. Gordon, et al.
A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy
Ann. Onc., July 5, 2010; (2010) mdq315v1.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
T. R. Asmis, E. Powell, C. S. Karapetis, D. J. Jonker, D. Tu, M. Jeffery, N. Pavlakis, P. Gibbs, L. Zhu, D.- A. Dueck, et al.
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care
Ann. Onc., July 5, 2010; (2010) mdq309v1.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
K. Izumi, K. Narimoto, K. Sugimoto, Y. Kobori, Y. Maeda, A. Mizokami, E. Koh, T. Yamada, S. Yano, and M. Namiki
The Role of Percutaneous Needle Biopsy in Differentiation of Renal Tumors
Jpn. J. Clin. Oncol., July 2, 2010; (2010) hyq076v1.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Compr Canc NetwHome page
D. S. Ettinger, W. Akerley, G. Bepler, M. G. Blum, A. Chang, R. T. Cheney, L. R. Chirieac, T. A. D'Amico, T. L. Demmy, A. K. P. Ganti, et al.
Non-Small Cell Lung Cancer
J Natl Compr Canc Netw, July 1, 2010; 8(7): 740 - 801.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Compr Canc NetwHome page
T. A. D'Amico
Operative Techniques in Early-Stage Lung Cancer
J Natl Compr Canc Netw, July 1, 2010; 8(7): 807 - 813.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Compr Canc NetwHome page
C. Aggarwal, N. Somaiah, and G. R. Simon
Biomarkers with Predictive and Prognostic Function in Non-Small Cell Lung Cancer: Ready for Prime Time?
J Natl Compr Canc Netw, July 1, 2010; 8(7): 822 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
I. J. Dahabreh, H. Linardou, P. Bouzika, V. Varvarigou, and S. Murray
TP53 Arg72Pro Polymorphism and Colorectal Cancer Risk: A Systematic Review and Meta-Analysis
Cancer Epidemiol. Biomarkers Prev., July 1, 2010; 19(7): 1840 - 1847.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
T. Sun, G.-S. M. Lee, L. Werner, M. Pomerantz, W. K. Oh, P. W. Kantoff, and M. L. Freedman
Inherited Variations in AR, ESR1, and ESR2 Genes Are Not Associated With Prostate Cancer Aggressiveness or With Efficacy of Androgen Deprivation Therapy
Cancer Epidemiol. Biomarkers Prev., July 1, 2010; 19(7): 1871 - 1878.
[Abstract] [Full Text] [PDF]

Home page
 J Am Board Fam MedHome page
R. C. Wender
Family Medicine in the Research Revolution
J Am Board Fam Med, July 1, 2010; 23(4): 431 - 439.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
E. Chang, J. Donahue, A. Smith, J. Hornick, J. N. Rao, J.-Y. Wang, and R. J. Battafarano
Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line
J. Thorac. Cardiovasc. Surg., July 1, 2010; 140(1): 225 - 232.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pediatric Oncology NursingHome page
R. Green, H. Horn, and J. M. Erickson
Eating Experiences of Children and Adolescents With Chemotherapy-Related Nausea and Mucositis
Journal of Pediatric Oncology Nursing, July 1, 2010; 27(4): 209 - 216.
[Abstract] [PDF]

Home page
 Diabetes CareHome page
E. Giovannucci, D. M. Harlan, M. C. Archer, R. M. Bergenstal, S. M. Gapstur, L. A. Habel, M. Pollak, J. G. Regensteiner, and D. Yee
Diabetes and Cancer: A consensus report
Diabetes Care, July 1, 2010; 33(7): 1674 - 1685.
[Full Text] [PDF]

Home page
 JCOHome page
G. L. Jackson, L. D. Melton, D. H. Abbott, L. L. Zullig, D. L. Ordin, S. C. Grambow, N. S. Hamilton, S. Y. Zafar, Z. F. Gellad, M. J. Kelley, et al.
Quality of Nonmetastatic Colorectal Cancer Care in the Department of Veterans Affairs
J. Clin. Oncol., July 1, 2010; 28(19): 3176 - 3181.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Link, F. Balaguer, Y. Shen, T. Nagasaka, J. J. Lozano, C. R. Boland, and A. Goel
Fecal MicroRNAs as Novel Biomarkers for Colon Cancer Screening
Cancer Epidemiol. Biomarkers Prev., July 1, 2010; 19(7): 1766 - 1774.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Paul, A. J. DeCastro, H. J. Lee, A. K. Smolarek, J. Y. So, B. Simi, C. X. Wang, R. Zhou, A. M. Rimando, and N. Suh
Dietary intake of pterostilbene, a constituent of blueberries, inhibits the {beta}-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats
Carcinogenesis, July 1, 2010; 31(7): 1272 - 1278.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
X. Wang and A. Schneider
HIF-2{alpha}-mediated activation of the epidermal growth factor receptor potentiates head and neck cancer cell migration in response to hypoxia
Carcinogenesis, July 1, 2010; 31(7): 1202 - 1210.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
Y. H. CHO, H. YAZICI, H.-C. WU, M. B. TERRY, K. GONZALEZ, M. QU, N. DALAY, and R. M. SANTELLA
Aberrant Promoter Hypermethylation and Genomic Hypomethylation in Tumor, Adjacent Normal Tissues and Blood from Breast Cancer Patients
Anticancer Res, July 1, 2010; 30(7): 2489 - 2496.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
V. R. ADAMS, D. L. DEREMER, B. STEVICH, C. A. MATTINGLY, B. GALLT, T. SUBRAMANIAN, J. M. TROUTMAN, and H. P. SPIELMANN
Anticancer Activity of Novel Unnatural Synthetic Isoprenoids
Anticancer Res, July 1, 2010; 30(7): 2505 - 2512.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
R. N. SEETHARAM, A. SOOD, A. BASU-MALLICK, L. H. AUGENLICHT, J. M. MARIADASON, and S. GOEL
Oxaliplatin Resistance Induced by ERCC1 Up-regulation Is Abrogated by siRNA-mediated Gene Silencing in Human Colorectal Cancer Cells
Anticancer Res, July 1, 2010; 30(7): 2531 - 2538.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
H. KIM, J. W. KANG, S. LEE, W. J. CHOI, L. S. JEONG, Y. YANG, J. T. HONG, and D. Y. YOON
A3 Adenosine Receptor Antagonist, Truncated Thio-Cl-IB-MECA, Induces Apoptosis in T24 Human Bladder Cancer Cells
Anticancer Res, July 1, 2010; 30(7): 2823 - 2830.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
K. IZUMI, A. MIZOKAMI, T. SHIMA, K. NARIMOTO, K. SUGIMOTO, Y. KOBORI, Y. MAEDA, H. KONAKA, E. KOH, and M. NAMIKI
Preliminary Results of Tranilast Treatment for Patients with Advanced Castration-resistant Prostate Cancer
Anticancer Res, July 1, 2010; 30(7): 3077 - 3081.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
F. LUMACHI, M. FABBRO, A. TREGNAGHI, L. ANTUNOVIC, F. BUI, D. CECCHIN, P. ZUCCHETTA, and A. FASSINA
Fine-Needle Aspiration Cytology and 99mTc-pertechnetate Scintigraphy Together in Patients with Differentiated Thyroid Carcinoma
Anticancer Res, July 1, 2010; 30(7): 3083 - 3086.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
P.-H. LIN, Y.-S. LU, C.-H. LIN, D.-Y. CHANG, C.-S. HUANG, A.-L. CHENG, and K.-H. YEH
Vinorelbine plus 24-Hour Infusion of High-dose 5-Fluorouracil and Leucovorin as Effective Palliative Chemotherapy for Breast Cancer Patients with Acute Disseminated Intravascular Coagulation
Anticancer Res, July 1, 2010; 30(7): 3087 - 3091.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Compr Canc NetwHome page
W. A. Hassen, F. A. Karsan, F. Abbas, Y. Beduk, A. El-Khodary, M. Ghosn, J. Khader, R. Khauli, D. M. Rabah, A. Shamseddine, et al.
Modification and Implementation of NCCN GuidelinesTM on Prostate Cancer in the Middle East and North Africa Region
J Natl Compr Canc Netw, July 1, 2010; 8(Suppl_3): S-26 - S-28.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Deguchi, M. Tanemura, E. Miyoshi, H. Nagano, T. Machida, Y. Ohmura, S. Kobayashi, S. Marubashi, H. Eguchi, Y. Takeda, et al.
Increased Immunogenicity of Tumor-Associated Antigen, Mucin 1, Engineered to Express {alpha}-Gal Epitopes: A Novel Approach to Immunotherapy in Pancreatic Cancer
Cancer Res., July 1, 2010; 70(13): 5259 - 5269.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Jiang, N. Chen, F. Zhao, X.-J. Wang, B. Kong, W. Zheng, and D. D. Zhang
High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
Cancer Res., July 1, 2010; 70(13): 5486 - 5496.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by American Cancer Society.